Drugs.com - Clinical Trials

Palatin’s Oral MC4R Agonist PL7737 Receives FDA Orphan Drug Designation for Obesity Due to Leptin Receptor Deficiency

Palatin’s Oral MC4R Agonist PL7737 Receives FDA Orphan ...

Mar 26, 2025 0

CRANBURY, N.J., March 25, 2025 /PRNewswire/ — Palatin Technologies, Inc. (NYSE A...

The United Laboratories and Novo Nordisk Announce Exclusive License Agreement for UBT251, a GLP-1/GIP/Glucagon Triple Receptor Agonist

The United Laboratories and Novo Nordisk Announce Exclu...

Mar 26, 2025 0

Guangdong, China and Bagsværd, Denmark, 24 March 2025 –The United Laboratories I...

PEP-Therapy Receives FDA Orphan Drug Designation for PEP-010 for Treatment of Pancreatic Cancer

PEP-Therapy Receives FDA Orphan Drug Designation for PE...

Mar 21, 2025 0

Paris (France), March 17, 2025 – PEP-Therapy, a clinical-stage biotechnology com...

Azer-cel Granted FDA Fast Track Designation in Blood Cancer DLBCL

Azer-cel Granted FDA Fast Track Designation in Blood Ca...

Mar 21, 2025 0

SYDNEY, Australia, 19 March 2025: Imugene Limited (ASX:IMU), a clinical-stage im...

Investigational Rinatabart Sesutecan (Rina-S®) Continues to Show Encouraging Antitumor Activity in Patients with Advanced Ovarian Cancer

Investigational Rinatabart Sesutecan (Rina-S®) Continue...

Mar 19, 2025 0

COPENHAGEN, Denmark; March 17, 2025 -- Genmab A/S (Nasdaq: GMAB) announced today...

New Data on Investigational Therapy Doxecitine and Doxribtimine for Thymidine Kinase 2 Deficiency Presented at Muscular Dystrophy Association (MDA) 2025 Conference

New Data on Investigational Therapy Doxecitine and Doxr...

Mar 19, 2025 0

Brussels (Belgium) 19 March 2025 – UCB, a global biopharmaceutical company, toda...

GRIN Therapeutics Receives FDA Orphan Drug Designation for Radiprodil for the Treatment of GRIN-Related Neurodevelopmental Disorder

GRIN Therapeutics Receives FDA Orphan Drug Designation ...

Mar 19, 2025 0

NEW YORK, NY, March 17, 2025– GRIN Therapeutics, Inc., a leader in the developme...

Immunovant Announces Positive Results for Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Studies

Immunovant Announces Positive Results for Batoclimab My...

Mar 19, 2025 0

NEW YORK, March 19, 2025 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a ...

Henlius Receives Orphan-Drug Designation for HLX22 (Innovative anti-HER2 mAb) in the U.S. for Gastric Cancer

Henlius Receives Orphan-Drug Designation for HLX22 (Inn...

Mar 19, 2025 0

Shanghai, China, March 19, 2025 - Shanghai Henlius Biotech, Inc. (2696.HK) annou...

Signal12 Achieves FDA Alignment, Accelerating Pro-ocular™ Towards Phase 3 Clinical Trials for Ocular Graft-versus-Host Disease

Signal12 Achieves FDA Alignment, Accelerating Pro-ocula...

Mar 19, 2025 0

BOSTON, March 18, 2025 /PRNewswire/ -- Signal12, Inc. (Signal12), a clinical-sta...

Nipocalimab, the First and Only Investigational Treatment to be Granted U.S. FDA Breakthrough Therapy Designation for the Treatment of Adults with Moderate-to-Severe Sjögren’s Disease, has now Received Fast Track Designation

Nipocalimab, the First and Only Investigational Treatme...

Mar 19, 2025 0

SPRING HOUSE, Pa., (March 18, 2025) – Johnson & Johnson (NYSE: JNJ) today announ...

Sarepta Therapeutics Shares Safety Update on Elevidys

Sarepta Therapeutics Shares Safety Update on Elevidys

Mar 18, 2025 0

CAMBRIDGE, Mass., March 18, 2025 -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), th...

Nurix Announces U.S. FDA Orphan Drug Designation Granted to Bexobrutideg (NX-5948) for the Treatment of Waldenström Macroglobulinemia

Nurix Announces U.S. FDA Orphan Drug Designation Grante...

Mar 18, 2025 0

SAN FRANCISCO, March 17, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasd...

FDA Approved Compassionate Use Treatment with Namodenoson in a Pancreatic Cancer Patient

FDA Approved Compassionate Use Treatment with Namodenos...

Mar 18, 2025 0

Ramat Gan, Israel, March 18, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (N...

SCORPIO-PEP Phase 3 Trial: Ensitrelvir is the First and Only COVID-19 Oral Antiviral to Demonstrate Prevention of COVID-19 as Post Exposure Prophylaxis

SCORPIO-PEP Phase 3 Trial: Ensitrelvir is the First and...

Mar 18, 2025 0

OSAKA, Japan, March 13, 2025 – Shionogi & Co., Ltd. (Head Office: Osaka, Japan; ...

Incyte Announces Positive Topline Results From Two Phase 3 Clinical Trials of Povorcitinib in Patients With Hidradenitis Suppurativa

Incyte Announces Positive Topline Results From Two Phas...

Mar 18, 2025 0

WILMINGTON, Del.--(BUSINESS WIRE)--Mar. 17, 2025-- Incyte (Nasdaq: INCY) today a...

Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600

Eton Pharmaceuticals Announces Positive Pivotal Clinica...

Mar 18, 2025 0

DEER PARK, Ill., March 14, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“...

Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human Clinical Trial of GLP-1 Implant NPM-115 in Obese or Overweight Adults

Vivani Medical Achieves First Implant and Full Enrollme...

Mar 18, 2025 0

ALAMEDA, Calif.--(BUSINESS WIRE) March 13, 2025 -- Vivani Medical, Inc. (NASDAQ:...

Zentalis Pharmaceuticals Presents Updated Azenosertib Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer

Zentalis Pharmaceuticals Presents Updated Azenosertib C...

Mar 18, 2025 0

SAN DIEGO, March 15, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (N...

BioArctic Receives Orphan Drug Designation for Exidavnemab the US

BioArctic Receives Orphan Drug Designation for Exidavne...

Mar 18, 2025 0

Stockholm, March 17, 2025 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) annou...

vTv Therapeutics Announces FDA has Lifted Clinical Hold on Cadisegliatin Program for Diabetes

vTv Therapeutics Announces FDA has Lifted Clinical Hold...

Mar 18, 2025 0

HIGH POINT, N.C., March 17, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasd...

Eneboparatide Met Primary Endpoint of Normalising Serum Calcium in Adults with Hypoparathyroidism at 24 weeks in CALYPSO Phase III Trial

Eneboparatide Met Primary Endpoint of Normalising Serum...

Mar 17, 2025 0

March 17, 2025 -- High-level results from the CALYPSO Phase III trial showed tha...

KRRO-110 Receives Orphan Drug Designation from U.S. FDA for Alpha-1 Antitrypsin Deficiency

KRRO-110 Receives Orphan Drug Designation from U.S. FDA...

Mar 15, 2025 0

CAMBRIDGE, Mass., March 14, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Na...

Sanofi Adopts FDA-Selected Flu Strains to Ensure Readiness for the 2025-26 Flu Season

Sanofi Adopts FDA-Selected Flu Strains to Ensure Readin...

Mar 14, 2025 0

BRIDGEWATER, N.J., March 14, 2025 /PRNewswire/ -- Sanofi announced today the imm...

1
2
3
4

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.